miR-203 promotes HaCaT cell overproliferation through targeting LXR-α and PPAR-γ

Cell Cycle. 2020 Aug;19(15):1928-1940. doi: 10.1080/15384101.2020.1783934. Epub 2020 Jun 28.

Abstract

Psoriasis is an immune-mediated chronic inflammatory skin disease. Keratinocyte hyperproliferation has been regarded as a significant event in psoriasis pathogenesis. Considering the vital role of miRNA-mediated mRNA repression in psoriasis pathogenesis, in the present study, we attempted to investigate the mechanism of keratinocyte overproliferation from the point of miRNA-mRNA regulation. Both online microarray expression profiles and experimental results indicated that the expression of LXR-α and PPAR-γ was downregulated in psoriasis lesion skin. LXR-α or PPAR-γ overexpression alone was sufficient to inhibit keratinocyte proliferation, decrease KRT5 and KRT14 protein levels and increase KRT1 and KRT10 protein levels. miR-203 negatively regulated LXR-α and PPAR-γ expression through direct targeting. miR-203 inhibition exerted the opposite effects to LXR-α or PPAR-γ overexpression on HaCaT cells. More importantly, LXR-α or PPAR-γ overexpression could markedly remarkably attenuate the effects of miR-203 overexpression in keratinocytes, indicating that miR-203 promotes keratinocyte proliferation by targeting LXR-α and PPAR-γ. In conclusion, the miR-203-LXR-α/PPAR-γ axis modulates the proliferation of keratinocytes and might be a novel target for psoriasis treatment, which needs further in vivo investigation.

Keywords: LXR-α; PPAR-γ; Psoriasis; keratinocyte hyperproliferation; miR-203.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Proliferation / genetics
  • HaCaT Cells / cytology*
  • HaCaT Cells / metabolism*
  • Humans
  • Keratinocytes / metabolism
  • Keratinocytes / pathology
  • Liver X Receptors / metabolism*
  • MicroRNAs / genetics
  • MicroRNAs / metabolism*
  • PPAR gamma / metabolism*
  • Psoriasis / genetics
  • Psoriasis / pathology

Substances

  • Liver X Receptors
  • MIRN203 microRNA, human
  • MicroRNAs
  • NR1H3 protein, human
  • PPAR gamma

Grants and funding

This study was supported by the National Natural Science Foundation [81573985].